Güllü IH - Search Results

1

Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.

Güllü IH, Celik I, Tekuzman G, Altunbaş M, Güler N, Barişta I, Alkiş N, Yalçin S, Kars A, Baltali E, Kansu E, Firat D. Güllü IH, et al. Tumori. 1996 May-Jun;82(3):228-31. Tumori. 1996. PMID: 8693599

2

Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.

Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G. Oztürk MA, et al. Chemotherapy. 2002 Dec;48(5):252-8. doi: 10.1159/000066768. Chemotherapy. 2002. PMID: 12476042 Clinical Trial.

3

Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: efficacy and prognostic factors.

Karaoğlu A, Yalcin S, Tekuzman G, Kars A, Celik I, Güler N, Ozişik Y, Türker A, Barişta I, Güllü I. Karaoğlu A, et al. Tumori. 2003 Mar-Apr;89(2):141-5. Tumori. 2003. PMID: 12841660

4

Long-term complications in Hodgkin's lymphoma survivors.

Kilickap S, Barista I, Ulger S, Celik I, Selek U, Güllü I, Yildiz F, Kars A, Ozisik Y, Tekuzman G. Kilickap S, et al. Tumori. 2012 Sep-Oct;98(5):601-6. doi: 10.1177/030089161209800510. Tumori. 2012. PMID: 23235755

5

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: gullu ih. J Chemother. 1996 Aug;8(4):310-4. doi: 10.1179/joc.1996.8.4.310. J Chemother. 1996. PMID: 8873839 Clinical Trial.

6

Ifosfamide and etoposide in previously treated patients with advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barişta I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: gullu ih. Tumori. 1997 Mar-Apr;83(2):604-7. doi: 10.1177/030089169708300225. Tumori. 1997. PMID: 9226029

7

Primary breast lymphomas--a retrospective analysis of twelve cases.

Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D. Barişta I, et al. Among authors: gullu ih. Acta Oncol. 2000;39(2):135-9. doi: 10.1080/028418600430671. Acta Oncol. 2000. PMID: 10859001

8

Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.

Kars A, Celik I, Kansu E, Tekuzman G, Ozişik Y, Güler N, Barişta I, Güllü I, Yalçin S, Altundağ K, Zengin N, Türker A, Hayran M, Baltali E, Firat D. Kars A, et al. Eur J Haematol. 1997 Aug;59(2):100-4. doi: 10.1111/j.1600-0609.1997.tb00732.x. Eur J Haematol. 1997. PMID: 9293857 Clinical Trial.

9

Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.

Yalçin S, Güllü I, Barişta I, Tekuzman G, Ozişik Y, Celik I, Kars A. Yalçin S, et al. Cancer Invest. 1998;16(5):297-302. doi: 10.3109/07357909809084647. Cancer Invest. 1998. PMID: 9627675 Clinical Trial.

10

Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies.

Koc Y, Akpek G, Kansu E, Kars A, Tekuzman G, Baltali E, Güler N, Barista I, Güllü I, Ozisik Y, Firat D. Koc Y, et al. Cancer Invest. 1998;16(6):355-65. doi: 10.3109/07357909809115774. Cancer Invest. 1998. PMID: 9679525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters